A Prospective, Open-label, Single-arm, Exploratory Clinical Trial to Evaluate the Safety and Tolerability of 225Ac-TR2205 Injection in Patients With Triple-negative Breast Cancer.

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This study is a prospective, single-center, single-arm, open-label research. It evaluates the safety and tolerability of 225Ac-TR2205 in patients with triple-negative breast cancer (TNBC), and assesses its radiation dosimetry and initial efficacy.
Epistemonikos ID: 69390184c88ad70d8e8c1dbc5cc5ad1c32fcbcfc
First added on: Jan 15, 2026